Free
Editorial Comments  |   March 1993
Patients with sickle cell disease were successfully treated with hydroxyurea, incrementally increased doses of intravenous erythropoietin, and oral iron supplements
Article Information
Editorial Comments   |   March 1993
Patients with sickle cell disease were successfully treated with hydroxyurea, incrementally increased doses of intravenous erythropoietin, and oral iron supplements
The Journal of the American Osteopathic Association, March 1993, Vol. 93, 313A. doi:10.7556/jaoa.1993.93.3.313A
The Journal of the American Osteopathic Association, March 1993, Vol. 93, 313A. doi:10.7556/jaoa.1993.93.3.313A
This content is PDF only. Please click on the PDF icon to access.
First Page Preview
First page PDF preview
First page PDF preview ×
View Large